Antiarrhythmic drugs for atrial fibrillation in the outpatient setting

被引:0
|
作者
Tseng, Andrew S. [1 ]
Desimone, Christopher V. [1 ]
Kowlgi, Gurukripa N. [1 ]
机构
[1] Mayo Clin, Dept Cardiovas Med, Rochester, MN USA
关键词
Atrial fibrillation; Cardiac arrhythmias; Outpatients; DIRECT ORAL ANTICOAGULANTS; HEART-FAILURE; DIGOXIN; DRONEDARONE; CAFFEINE; RISK; METAANALYSIS; ASSOCIATION; ARRHYTHMIAS; DOFETILIDE;
D O I
10.23736/S0026-4806.23.08524-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With burgeoning evidence for early rhythm control in patients with atrial fibrillation (AF), the management of AF in the outpatient setting has become more challenging. The primary care clinician often serves as the frontline in the pharmacologic management of AF. Because of drug interactions and the risk of proarrhythmia, many clinicians remain hesitant about the initiation and chronic management of antiarrhythmic drug prescriptions. However, with the likely increased use of antiarrhythmics for early rhythm control, understanding and familiarity with these medications have likewise become more important, especially since patients with AF probably have other non-cardiac medical conditions that can impact their antiarrhythmic therapy. In this comprehensive review, we provide informative, high-yield cases and edifying references that will help primary care providers become comfortable handling various clinical scenarios.
引用
收藏
页码:839 / 849
页数:11
相关论文
共 50 条
  • [1] Antiarrhythmic Drugs for Atrial Fibrillation in the Outpatient Setting: Common Clinical Scenarios and Pearls for the Primary Care Clinician
    Tseng, Andrew S.
    Kowlgi, Gurukripa N.
    V. DeSimone, Christopher
    MAYO CLINIC PROCEEDINGS, 2021, 96 (08) : 2230 - 2242
  • [2] Antiarrhythmic drugs for atrial fibrillation
    Marinelli, Alessandro
    Capucci, Alessandro
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (08) : 1201 - 1215
  • [3] Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation
    LaPointe, Nancy M. Allen
    Governale, Laura
    Watkins, Jerry
    Mutgund, Jyotsna
    Anstrom, Kevin J.
    AMERICAN HEART JOURNAL, 2007, 154 (05) : 893 - 898
  • [4] The role of antiarrhythmic drugs in atrial fibrillation
    Bontempi, Luca
    Vassanelli, Francesca
    Lipari, Alessandro
    Pagnoni, Carlo
    Locantore, Elisa
    ElMaghawry, Mohamed
    Salghetti, Francesca
    Cerini, Manuel
    Curnis, Antonio
    GIORNALE ITALIANO DI CARDIOLOGIA, 2013, 14 (03) : 76S - 81S
  • [5] Emerging Antiarrhythmic Drugs for Atrial Fibrillation
    Saljic, Arnela
    Heijman, Jordi
    Dobrev, Dobromir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [6] The Association of With Antiarrhythmic Drugs for Atrial Fibrillation
    Reiffel, James A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (11) : e79 - e79
  • [7] Oral bolus of IC antiarrhythmic drugs for atrial fibrillation: Outpatient versus inpatient administration
    Marrouche, NF
    Brachmann, J
    Guenther, J
    Schbgilla, V
    Saliba, W
    Tomassoni, G
    Beheiry, S
    Pisano, E
    Bash, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 98A - 98A
  • [8] New antiarrhythmic drugs for prevention of atrial fibrillation
    Goldstein, RN
    Stambler, BS
    PROGRESS IN CARDIOVASCULAR DISEASES, 2005, 48 (03) : 193 - 208
  • [9] ANTIARRHYTHMIC DRUGS IN THE MANAGEMENT OF ATRIAL-FIBRILLATION
    COWAN, JC
    BRITISH HEART JOURNAL, 1993, 70 (04): : 304 - 306
  • [10] Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs
    Schilling, Richard J.
    HEART, 2010, 96 (05) : 333 - 338